We are a precision obesity company focused on conquering obesity through use of proprietary genetic tests, unique data sets and advanced analytics. Our Phenomix Sciences Obesity Platform leverages our capabilities in genetics, data science and clinical development to improve patient clinical outcomes and lower healthcare costs. In 2023, we launched our novel phenotyping test, the MyPhenome Test, for use by obesity specialists to help determine the correct intervention for their patients.